Klencke Barbara
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Klencke Barbara. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| XNCR | Award / Grant | 13,686 | — | — | Jun 12, 2025 | |
| TCRX | Purchase | 5,000 | $5.29 | $26,450 | Sep 23, 2024 | |
| TCRX | Purchase | 5,000 | $5.69 | $28,450 | Aug 26, 2024 | |
| XNCR | Award / Grant | 5,986 | — | — | Jun 13, 2024 | |
| TCRX | Purchase | 5,000 | $5.08 | $25,400 | Dec 14, 2023 | |
| 0001290149 | Chief Medical Officer | Disposition | 5,000 | $55.00 | $275,000 | Jul 1, 2022 |
| 0001290149 | Chief Development Officer | Purchase | 3,325 | $12.25 | $40,731 | Aug 18, 2020 |
| 0001290149 | Chief Development Officer | Purchase | 108,000 | $0.44 | $47,520 | Aug 22, 2019 |